Apr 9, 2025
11:00am - 11:30am
Summit, Level 3, Room 336
George Malliaras1
University of Cambridge1
Neurotechnology provides a new means of addressing disease via the electrical stimulation of tissues: Deep brain stimulation, for example, has shown exceptional promise in the treatment of neurological and neuropsychiatric disorders and in human-machine interfaces. To bring these technologies to patients at scale, however, significant challenges remain to be addressed. Key among these is our ability to establish stable and efficient interfaces between electronics and the human body. I will show examples of how this can be achieved using new implantable organic electronic materials and devices engineered to communicate with the body and evolve with it.